Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 26, Issue 3, 2015, Pages 597-610

  Gangadhariah, Mahesha H ^a   Luther, James M ^a   Garcia, Victor ^b   Paueksakon, Paisit ^c   Zhang, Ming Zhi ^a   Hayward, Simon W ^c   Love, Harold D ^c   Falck, John R ^d   Manthati, Vijaya L ^d   Imig, John D ^e   Schwartzman, Michal L ^b   Zent, Roy ^a,f   Capdevila, Jorge H ^a   Pozzi, Ambra ^a,f  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f Veterans Affairs Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ANTIHYPERTENSIVE AGENT; COLLAGEN; CYTOCHROME P450 4A; CYTOCHROME P450 4A12; CYTOCHROME P450 4A14; GLUCOSE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; RESERPINE; SODIUM; UNCLASSIFIED DRUG; [2,5,8,11,14,17 HEXAOXANONADECAN 19 YL 20 HYDROXYICOSA 6,15 DIENOATE]; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; CYP4A14 PROTEIN, MOUSE; CYTOCHROME P450; HYDROXYICOSATETRAENOIC ACID;

ALBUMINURIA; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; CASTRATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; EC50; ELECTRON MICROSCOPY; FEMALE; GLOMERULUS BASEMENT MEMBRANE; GLUCOSE BLOOD LEVEL; HYPERTENSION; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY MICROSOME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM URINE LEVEL; UPREGULATION; VASOCONSTRICTION; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPLICATION; DIABETIC NEPHROPATHIES; GENETICS; KNOCKOUT MOUSE; METABOLISM; ORCHIECTOMY; PATHOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; COLLAGEN; CYTOCHROME P-450 ENZYME SYSTEM; DIABETIC NEPHROPATHIES; GLOMERULAR BASEMENT MEMBRANE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYDROXYEICOSATETRAENOIC ACIDS; HYPERTENSION; MALE; MICE, KNOCKOUT; ORCHIECTOMY; RENIN-ANGIOTENSIN SYSTEM; RESERPINE; SODIUM;

EID: 84924052484     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013090980     Document Type: Article

References (35)

1. Whiting DR, Guariguata L, Weil C, Shaw J: IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94: 311-321, 2011
2. Craig DW, Millis MP, DiStefano JK: Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to type 1 diabetes. Diabet Med 26: 1090-1098, 2009
3. Sandholm N, Salem RM, McKnight AJ, Brennan EP, Forsblom C, Isakova T, McKay GJ, Williams WW, Sadlier DM, Mäkinen VP, Swan EJ, Palmer C, Boright AP, Ahlqvist E, Deshmukh HA, Keller BJ, Huang H, Ahola AJ, Fagerholm E, Gordin D, Harjutsalo V, He B, Heikkilä O, Hietala K, Kytö J, Lahermo P, Lehto M, Lithovius R, Osterholm AM, Parkkonen M, Pitkäniemi J, Rosengård-Bärlund M, Saraheimo M, Sarti C, Söderlund J, Soro-Paavonen A, Syreeni A, Thorn LM, Tikkanen H, Tolonen N, Tryggvason K, Tuomilehto J, Wadén J, Gill GV, Prior S, Guiducci C, Mirel DB, Taylor A, Hosseini SM, Parving HH, Rossing P, Tarnow L, Ladenvall C, Alhenc-Gelas F, Lefebvre P, Rigalleau V, Roussel R, Tregouet DA, Maestroni A, Maestroni S, Falhammar H, Gu T, Möllsten A, Cimponeriu D, Ioana M, Mota M, Mota E, Serafinceanu C, Stavarachi M, Hanson RL, Nelson RG, Kretzler M, Colhoun HM, Panduru NM, Gu HF, Brismar K, Zerbini G, Hadjadj S, Marre M, Groop L, Lajer M, Bull SB, Waggott D, Paterson AD, Savage DA, Bain SC, Martin F, Hirschhorn JN, Godson C, Florez JC, Groop PH, Maxwell AP; DCCT/EDIC Research Group: New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet 8: e1002921, 2012
4. Sun YM, Su Y, Li J, Wang LF: Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochem Biophys Res Commun 433: 359-361, 2013
5. Pirkle JL, Freedman BI: Hypertension and chronic kidney disease: Controversies in pathogenesis and treatment. Minerva Urol Nefrol 65: 37-50, 2013
6. Volpe CM, Nogueira-Machado JA: The dual role of free fatty acid signaling in inflammation and therapeutics. Recent Pat Endocr Metab Immune Drug Discov 7: 189-197, 2013.
7. Powell PK, Wolf I, Jin R, Lasker JM: Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: Involvement of CYP4F2 and CYP4A11. J Pharmacol Exp Ther 285: 1327-1336, 1998
8. Capdevila JH, Harris RC, Falck JR: Microsomal cytochrome P450 and eicosanoid metabolism. Cell Mol Life Sci 59: 780-789, 2002
9. Lasker JM, Chen WB, Wolf I, Bloswick BP, Wilson PD, Powell PK: Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J Biol Chem 275: 4118-4126, 2000
10. Wu CC, Gupta T, Garcia V, Ding Y, Schwartzman ML: 20-HETE and blood pressure regulation: Clinical implications. Cardiol Rev 22: 1-12. 2014
11. Ward NC, Rivera J, Hodgson J, Puddey IB, Beilin LJ, Falck JR, Croft KD: Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans. Circulation 110: 438-443, 2004
12. Nowicki S, Chen SL, Aizman O, Cheng XJ, Li D, Nowicki C, Nairn A, Greengard P, Aperia A: 20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. Role in regulation of rat renal Na+,K+-ATPase. J Clin Invest 99: 1224-1230, 1997
13. Yu M, Lopez B, Dos Santos EA, Falck JR, Roman RJ: Effects of 20-HETE on Na+ transport and Na+ -K+ -ATPase activity in the thick ascending loop of Henle. Am J Physiol Regul Integr Comp Physiol 292: R2400-R2405, 2007
14. Ominato M, Satoh T, Katz AI: Regulation of Na-K-ATPase activity in the proximal tubule: Role of the protein kinase C pathway and of eicosanoids. J Membr Biol 152: 235-243, 1996
15. Eid AA, Gorin Y, Fagg BM, Maalouf R, Barnes JL, Block K, Abboud HE: Mechanisms of podocyte injury in diabetes: Role of cytochrome P450 and NADPH oxidases. Diabetes 58: 1201-1211, 2009
16. Muller DN, Schmidt C, Barbosa-Sicard E, Wellner M, Gross V, Hercule H, Markovic M, Honeck H, Luft FC, Schunck WH: Mouse Cyp4a isoforms: Enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation. Biochem J 403: 109-118, 2007
17. Holla VR, Adas F, Imig JD, Zhao X, Price E Jr, Olsen N, Kovacs WJ, Magnuson MA, Keeney DS, Breyer MD, Falck JR, Waterman MR, Capdevila JH: Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc Natl Acad Sci U S A 98: 5211-5216, 2001
18. Wu CC, Mei S, Cheng J, Ding Y, Weidenhammer A, Garcia V, Zhang F, Gotlinger K, Manthati VL, Falck JR, Capdevila JH, Schwartzman ML: Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. J Am Soc Nephrol 24: 1288-1296, 2013
19. Van Buren PN, Toto RD: The pathogenesis and management of hypertension in diabetic kidney disease. Med Clin North Am 97: 31-51, 2013
20. Weil EJ, Lemley KV, Mason CC, Yee B, Jones LI, Blouch K, Lovato T, Richardson M, Myers BD, Nelson RG: Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int 82: 1010-1017, 2012
21. Sodhi K, Wu CC, Cheng J, Gotlinger K, Inoue K, Goli M, Falck JR, Abraham NG, Schwartzman ML: CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent. Hypertension 56: 871-878, 2010
22. Cheng J, Garcia V, Ding Y, Wu CC, Thakar K, Falck JR, Ramu E, Schwartzman ML: Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction. Arterioscler Thromb Vasc Biol 32: 1917-1924, 2012
23. Park F, Sweeney WE Jr, Jia G, Akbulut T, Mueller B, Falck JR, Birudaraju S, Roman RJ, Avner ED: Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD. Am J Physiol Renal Physiol 296: F575-F582, 2009
24. Nilakantan V, Maenpaa C, Jia G, Roman RJ, Park F: 20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells. Am J Physiol Renal Physiol 294: F562-F570, 2008
25. Eid S, Maalouf R, Jaffa AA, Nassif J, Hamdy A, Rashid A, Ziyadeh FN, Eid AA: 20-HETE and EETs in diabetic nephropathy: A novel mechanistic pathway. PLoS ONE 8: e70029, 2013
26. Ma YH, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS, Harder DR, Roman RJ: 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72: 126-136, 1993
27. Quigley R, Chakravarty S, Zhao X, Imig JD, Capdevila JH: Increased renal proximal convoluted tubule transport contributes to hypertension in Cyp4a14 knockout mice. Nephron, Physiol 113: 23-28, 2009
28. Fidelis P, Wilson L, Thomas K, Villalobos M, Oyekan AO: Renal function and vasomotor activity in mice lacking the Cyp4a14 gene. Exp Biol Med (Maywood) 235: 1365-1374, 2010
29. Ogawa S, Matsushima M, Mori T, Okamura M, Senda M, Sakamoto T, Nako K, Ito S: Identification of the stages of diabetic nephropathy at which angiotensin II receptor blockers most effectively suppress albuminuria. Am J Hypertens 26: 1064-1069, 2013
30. Argyrakopoulou G, Tsioufis C, Sdraka E, Tsiachris D, Makrilakis K, Stefanadis C: Antihypertensive treatment in diabetic patients. Review of current data. Maturitas 75: 142-147, 2013
31. Capdevila JH, Falck JR, Dishman E, Karara A: Cytochrome P-450 arachidonate oxygenase. Methods Enzymol 187: 385-394, 1990
32. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM: Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A 92: 3521-3525, 1995
33. Chen X, Moeckel G, Morrow JD, Cosgrove D, Harris RC, Fogo AB, Zent R, Pozzi A: Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury. Am J Pathol 165: 617-630, 2004
34. Mundel P, Reiser J, Kriz W: Induction of differentiation in cultured rat and human podocytes. J Am Soc Nephrol 8: 697-705, 1997
35. Prakash C, Zhang JY, Falck JR, Chauhan K, Blair IA: 20-Hydroxyeicosatetraenoic acid is excreted as a glucuronide conjugate in human urine. Biochem Biophys Res Commun 185: 728-733, 1992